Back to BAKER BROS. ADVISORS LP

ABCL
Showing 8 of 22 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in ABCELLERA BIOLOGICS INC

BAKER BROS. ADVISORS LP holds 30.3M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $105.7M as of 2026-Q1. The position was increased (+10.0% shares). ABCL represents 0.6% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$105.7M

Current Shares

30.3M

Total Value Change

+$24.2M

Total Shares Change

+2.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
30.3M
+10.0%
$105.7M0.6%$3.71
47
2025-Q4
Unchanged
27.5M
0.0%
$94.1M0.6%$3.45
0
2025-Q3
Unchanged
27.5M
0.0%
$138.5M1.0%$4.87
0
2025-Q2
Unchanged
27.5M
0.0%
$94.4M0.9%$3.61
0
2025-Q1
Unchanged
27.5M
0.0%
$61.4M0.7%$2.31
0
2024-Q4
Unchanged
27.5M
0.0%
$80.7M0.9%$2.82
0
2024-Q3
Unchanged
27.5M
0.0%
$71.6M0.7%$2.61
0
2024-Q2
Unchanged
27.5M
0.0%
$81.5M1.0%$2.96
0

Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used